Global Antibacterial Drugs Market 2023-2027

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	179 Pages	TechNavio	August, 2023	INF18180551

Best Price Guarantee
Price	from $2,500
Length	179 Pages
Publisher	TechNavio
Published Date	August, 2023
SKU	INF18180551

Global Antibacterial Drugs Market 2023-2027

The antibacterial drugs market is forecasted to grow by USD 9908.11 mn during 2022-2027, accelerating at a CAGR of 4.21% during the forecast period. The report on the antibacterial drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of bacterial infections, growing awareness of various diseases and their treatment caused by bacteria, and rising aging population globally.

Technavio's antibacterial drugs market is segmented as below:

By Route Of Administration

Intravenous
Oral
Others

By Drug Class

B-lactam
Quinolones
Macrolides
Tetracyclines
Others

By Geography

Asia
North America
Europe
Rest of World (ROW)

This study identifies the application of nanotechnology in antibacterial drugs as one of the prime reasons driving the antibacterial drugs market growth during the next few years. Also, rising priorities for research and development of age-appropriate antibiotics and increasing number of partnerships and collaborations will lead to sizable demand in the market.

The report on the antibacterial drugs market covers the following areas:

Antibacterial drugs market sizing
Antibacterial drugs market forecast
Antibacterial drugs market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading antibacterial drugs market vendors that include AbbVie Inc., Basilea Pharmaceutica Ltd., Bayer AG, Binnopharm Group LLC, Bristol Myers Squibb Co., Eli Lilly and Co., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Kyorin Pharmaceutical Co. Ltd., Lupin Ltd., Merck KGaA, Novartis AG, Paratek Pharmaceuticals Inc., Pfizer Inc., Sanofi, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Cipla Ltd., Melinta Therapeutics LLC, and Shionogi and Co. Ltd.. Also, the antibacterial drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Executive Summary
- Market overview
  - Table Executive Summary – Chart on Market Overview
  - Table Executive Summary – Data Table on Market Overview
  - Table Executive Summary – Chart on Global Market Characteristics
  - Table Executive Summary – Chart on Market by Geography
  - Table Executive Summary – Chart on Market Segmentation by Route of Administration
  - Table Executive Summary – Chart on Market Segmentation by Drug Class
  - Table Executive Summary – Chart on Incremental Growth
  - Table Executive Summary – Data Table on Incremental Growth
  - Table Executive Summary – Chart on Vendor Market Positioning
Market Landscape
- Market ecosystem
  - Table Parent market
  - Table Market Characteristics
Market Sizing
- Market definition
  - Table Offerings of vendors included in the market definition
- Market segment analysis
  - Table Market segments
- Market size 2022
- Market outlook: Forecast for 2022-2027
  - Table Chart on Global - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Global - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Global Market: Year-over-year growth 2022-2027 (%)
  - Table Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Historic Market Size
- Global antibacterial drugs market 2017 - 2021
  - Table Historic Market Size – Data Table on global antibacterial drugs market 2017 - 2021 ($ million)
- Route of administration Segment Analysis 2017 - 2021
  - Table Historic Market Size – Route of administration Segment 2017 - 2021 ($ million)
- Drug class Segment Analysis 2017 - 2021
  - Table Historic Market Size – Drug class Segment 2017 - 2021 ($ million)
- Geography Segment Analysis 2017 - 2021
  - Table Historic Market Size – Geography Segment 2017 - 2021 ($ million)
- Country Segment Analysis 2017 - 2021
  - Table Historic Market Size – Country Segment 2017 - 2021 ($ million)
Five Forces Analysis
- Five forces summary
  - Table Five forces analysis - Comparison between 2022 and 2027
- Bargaining power of buyers
  - Table Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
- Bargaining power of suppliers
  - Table Bargaining power of suppliers – Impact of key factors in 2022 and 2027
- Threat of new entrants
  - Table Threat of new entrants – Impact of key factors in 2022 and 2027
- Threat of substitutes
  - Table Threat of substitutes – Impact of key factors in 2022 and 2027
- Threat of rivalry
  - Table Threat of rivalry – Impact of key factors in 2022 and 2027
- Market condition
  - Table Chart on Market condition - Five forces 2022 and 2027
Market Segmentation by Route of Administration
- Market segments
  - Table Chart on Route of Administration - Market share 2022-2027 (%)
  - Table Data Table on Route of Administration - Market share 2022-2027 (%)
- Comparison by Route of Administration
  - Table Chart on Comparison by Route of Administration
  - Table Data Table on Comparison by Route of Administration
- Intravenous - Market size and forecast 2022-2027
  - Table Chart on Intravenous - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Intravenous - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Intravenous - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Intravenous - Year-over-year growth 2022-2027 (%)
- Oral - Market size and forecast 2022-2027
  - Table Chart on Oral - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Oral - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Oral - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Oral - Year-over-year growth 2022-2027 (%)
- Others - Market size and forecast 2022-2027
  - Table Chart on Others - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Others - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Others - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Others - Year-over-year growth 2022-2027 (%)
- Market opportunity by Route of Administration
  - Table Market opportunity by Route of Administration ($ million)
  - Table Data Table on Market opportunity by Route of Administration ($ million)
Market Segmentation by Drug Class
- Market segments
  - Table Chart on Drug Class - Market share 2022-2027 (%)
  - Table Data Table on Drug Class - Market share 2022-2027 (%)
- Comparison by Drug Class
  - Table Chart on Comparison by Drug Class
  - Table Data Table on Comparison by Drug Class
- B-lactam - Market size and forecast 2022-2027
  - Table Chart on B-lactam - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on B-lactam - Market size and forecast 2022-2027 ($ million)
  - Table Chart on B-lactam - Year-over-year growth 2022-2027 (%)
  - Table Data Table on B-lactam - Year-over-year growth 2022-2027 (%)
- Quinolones - Market size and forecast 2022-2027
  - Table Chart on Quinolones - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Quinolones - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Quinolones - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Quinolones - Year-over-year growth 2022-2027 (%)
- Macrolids - Market size and forecast 2022-2027
  - Table Chart on Macrolids - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Macrolids - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Macrolids - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Macrolids - Year-over-year growth 2022-2027 (%)
- Tetracyclins - Market size and forecast 2022-2027
  - Table Chart on Tetracyclins - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Tetracyclins - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Tetracyclins - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Tetracyclins - Year-over-year growth 2022-2027 (%)
- Others - Market size and forecast 2022-2027
  - Table Chart on Others - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Others - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Others - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Others - Year-over-year growth 2022-2027 (%)
- Market opportunity by Drug Class
  - Table Market opportunity by Drug Class ($ million)
  - Table Data Table on Market opportunity by Drug Class ($ million)
Customer Landscape
- Customer landscape overview
  - Table Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Geographic Landscape
- Geographic segmentation
  - Table Chart on Market share by geography 2022-2027 (%)
  - Table Data Table on Market share by geography 2022-2027 (%)
- Geographic comparison
  - Table Chart on Geographic comparison
  - Table Data Table on Geographic comparison
- Asia - Market size and forecast 2022-2027
  - Table Chart on Asia - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Asia - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Asia - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Asia - Year-over-year growth 2022-2027 (%)
- North America - Market size and forecast 2022-2027
  - Table Chart on North America - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on North America - Market size and forecast 2022-2027 ($ million)
  - Table Chart on North America - Year-over-year growth 2022-2027 (%)
  - Table Data Table on North America - Year-over-year growth 2022-2027 (%)
- Europe - Market size and forecast 2022-2027
  - Table Chart on Europe - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Europe - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Europe - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Europe - Year-over-year growth 2022-2027 (%)
- Rest of World (ROW) - Market size and forecast 2022- 2027
  - Table Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
- US - Market size and forecast 2022-2027
  - Table Chart on US - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on US - Market size and forecast 2022-2027 ($ million)
  - Table Chart on US - Year-over-year growth 2022-2027 (%)
  - Table Data Table on US - Year-over-year growth 2022-2027 (%)
- China - Market size and forecast 2022-2027
  - Table Chart on China - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on China - Market size and forecast 2022-2027 ($ million)
  - Table Chart on China - Year-over-year growth 2022-2027 (%)
  - Table Data Table on China - Year-over-year growth 2022-2027 (%)
- Germany - Market size and forecast 2022-2027
  - Table Chart on Germany - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Germany - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Germany - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Germany - Year-over-year growth 2022-2027 (%)
- Japan - Market size and forecast 2022-2027
  - Table Chart on Japan - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Japan - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Japan - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Japan - Year-over-year growth 2022-2027 (%)
- UK - Market size and forecast 2022-2027
  - Table Chart on UK - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on UK - Market size and forecast 2022-2027 ($ million)
  - Table Chart on UK - Year-over-year growth 2022-2027 (%)
  - Table Data Table on UK - Year-over-year growth 2022-2027 (%)
- Market opportunity by geography
  - Table Market opportunity by geography ($ million)
  - Table Data Tables on Market opportunity by geography ($ million)
Drivers, Challenges, and Trends
- Market drivers
  - Increasing prevalence of bacterial infections
  - Growing awareness of various diseases and their treatment caused by bacteria
  - Rising aging population globally
- Market challenges
  - Development of antibiotic-resistant strains
  - Regulatory hurdles related to developing antibacterial drugs
  - Increasing competition from generics
- Impact of drivers and challenges
  - Table Impact of drivers and challenges in 2022 and 2027
- Market trends
  - Application of nanotechnology in antibacterial drugs
  - Rising priorities for research and development of age-appropriate antibiotics
  - Increasing number of partnerships and collaborations
Vendor Landscape
- Overview
- Vendor landscape
  - Table Overview on Criticality of inputs and Factors of differentiation
- Landscape disruption
  - Table Overview on factors of disruption
- Industry risks
  - Table Impact of key risks on business
Vendor Analysis
- Vendors covered
  - Table Vendors covered
- Market positioning of vendors
  - Table Matrix on vendor position and classification
- AbbVie Inc.
  - Table AbbVie Inc. - Overview
  - Table AbbVie Inc. - Product / Service
  - Table AbbVie Inc. - Key news
  - Table AbbVie Inc. - Key offerings
- Bayer AG
  - Table Bayer AG - Overview
  - Table Bayer AG - Business segments
  - Table Bayer AG - Key news
  - Table Bayer AG - Key offerings
  - Table Bayer AG - Segment focus
- Bristol Myers Squibb Co.
  - Table Bristol Myers Squibb Co. - Overview
  - Table Bristol Myers Squibb Co. - Product / Service
  - Table Bristol Myers Squibb Co. - Key news
  - Table Bristol Myers Squibb Co. - Key offerings
- Cipla Ltd.
  - Table Cipla Ltd. - Overview
  - Table Cipla Ltd. - Business segments
  - Table Cipla Ltd. - Key news
  - Table Cipla Ltd. - Key offerings
  - Table Cipla Ltd. - Segment focus
- Eli Lilly and Co.
  - Table Eli Lilly and Co. - Overview
  - Table Eli Lilly and Co. - Product / Service
  - Table Eli Lilly and Co. - Key news
  - Table Eli Lilly and Co. - Key offerings
- F. Hoffmann La Roche Ltd.
  - Table F. Hoffmann La Roche Ltd. - Overview
  - Table F. Hoffmann La Roche Ltd. - Business segments
  - Table F. Hoffmann La Roche Ltd. - Key news
  - Table F. Hoffmann La Roche Ltd. - Key offerings
  - Table F. Hoffmann La Roche Ltd. - Segment focus
- GlaxoSmithKline Plc
  - Table GlaxoSmithKline Plc - Overview
  - Table GlaxoSmithKline Plc - Business segments
  - Table GlaxoSmithKline Plc - Key news
  - Table GlaxoSmithKline Plc - Key offerings
  - Table GlaxoSmithKline Plc - Segment focus
- Kyorin Pharmaceutical Co. Ltd.
  - Table Kyorin Pharmaceutical Co. Ltd. - Overview
  - Table Kyorin Pharmaceutical Co. Ltd. - Product / Service
  - Table Kyorin Pharmaceutical Co. Ltd. - Key offerings
- Lupin Ltd.
  - Table Lupin Ltd. - Overview
  - Table Lupin Ltd. - Product / Service
  - Table Lupin Ltd. - Key news
  - Table Lupin Ltd. - Key offerings
- Merck KGaA
  - Table Merck KGaA - Overview
  - Table Merck KGaA - Business segments
  - Table Merck KGaA - Key news
  - Table Merck KGaA - Key offerings
  - Table Merck KGaA - Segment focus
- Novartis AG
  - Table Novartis AG - Overview
  - Table Novartis AG - Business segments
  - Table Novartis AG - Key offerings
  - Table Novartis AG - Segment focus
- Paratek Pharmaceuticals Inc.
  - Table Paratek Pharmaceuticals Inc. - Overview
  - Table Paratek Pharmaceuticals Inc. - Product / Service
  - Table Paratek Pharmaceuticals Inc. - Key offerings
- Pfizer Inc.
  - Table Pfizer Inc. - Overview
  - Table Pfizer Inc. - Product / Service
  - Table Pfizer Inc. - Key news
  - Table Pfizer Inc. - Key offerings
- Sanofi
  - Table Sanofi - Overview
  - Table Sanofi - Business segments
  - Table Sanofi - Key news
  - Table Sanofi - Key offerings
  - Table Sanofi - Segment focus
- Teva Pharmaceutical Industries Ltd.
  - Table Teva Pharmaceutical Industries Ltd. - Overview
  - Table Teva Pharmaceutical Industries Ltd. - Business segments
  - Table Teva Pharmaceutical Industries Ltd. - Key news
  - Table Teva Pharmaceutical Industries Ltd. - Key offerings
  - Table Teva Pharmaceutical Industries Ltd. - Segment focus
Appendix
- Scope of the report
  - Market definition
  - Objectives
  - Notes and caveats
- Inclusions and exclusions checklist
  - Table Inclusions checklist
  - Table Exclusions checklist
- Currency conversion rates for US$
  - Table Currency conversion rates for US$
- Research methodology
  - Table Research methodology
  - Table Validation techniques employed for market sizing
  - Table Information sources
- List of abbreviations
  - Table List of abbreviations